ORKTS logo
Chinese University of Hong Kong logo
 test
Knowledge Transfer Initiatives

Latest Events

2017

Make Money the Biotech Way《生物科技創投攻略》

The Office of Research and Knowledge Transfer Services (ORKTS) of The Chinese University of Hong Kong would like to bring to your attention the captioned event. We are honoured that our speaker, Dr. Kenneth FONG, will be sharing with us some of his experiences in transitioning from academia to building biotechnology startup and venture captalist firm to support biotech companies. Event details are as follows:

香港中文大學研究及知識轉移服務處(ORKTS)誠摯邀請各中大教研人員/同學/畢業生/其他各界人士出席方瑞賢博士的研討會。屆時方博士將分享他由學術界過渡至創辦生物科技初創企業以及創業投資公司的寶貴經驗。研討會資料及講者簡介詳見下表:

Date 26 Apr 2017  (Wed)
Time 4:30pm
Venue 104, YC Liang Hall 潤昌堂104講廳
Speaker Dr. Kenneth FONG - Chairman, Kenson ventures LLC
方瑞賢博士, 恆信創業投資公司主席
Moderator Dr Albert Wai-Kit Chan, Managing Partner, Law Offices of Albert Wai-Kit Chan, PLLC
陳偉傑博士 - 美國Albert Wai-Kit Chan律師事務所合夥人
Organisers ORKTS, CUHK
Registration RSVP here for free (light networking refreshments will be served)
Event flyer Download here
Enquiry Dr. Ken Chow, This email address is being protected from spambots. You need JavaScript enabled to view it., +852 3943 1453

About the Speaker: Dr. Kenneth Fong has spent the last 32 years in the biotech industry after completing his academic pursuit in biomedical research. He is best known for founding the biotech company, Clontech in 1984 where he had cultivated it to be one of the largest biomedical tool companies founded by an Asian American in the US (400 people with 65 PhD scientists). Clontech was sold to Becton Dickinson in 1999 and Dr. Fong has continued his career as a Venture capitalist with Kenson Ventures that he founded. He has since cultivated more than 10 highly successful entrepreneurs, advising them and working with them on the growth of their companies.

Currently, he sits on the board of 4 biotech companies and he was intimately involved with the Merge/Aquisition and Initial public offering (IPO) of more than 10 companies that are worth north of $3 billion. These companies range from research tools, medical diagnostics and drug development. In almost all cases, Dr. Fong has been instrumental in providing strategies for sustainable growth, value creation and liquidity. Those successful entrepreneurs have moved on to assume leadership in other start-up and mid-sized companies, which in turn leads to a new generation of entrepreneurs.

Dr. Fong has held a number of leadership positions over the years. He served as the President of the Society of Chinese Bioscientists in North America (2006-07) and President of the Bay Area Asian American Manufacturers’ Association (AAMA, 1987). He was also the member of the Board of Trustees of the California State University System (2006-13). His philanthropic interests include scholarships to San Francisco State University, the Kenneth Fong-Hearst endowed scholarships to the CSU system and 40 student scholarships to Peking university. In 2006, he was involved with establishing the Fong Optometry and Medical library at UC Berkeley, and more recently an endowed professorship at Stanford university and a technology translation endowed fund at San Francisco State University. 

Dr. Fong obtained his PhD from Indiana university and his BS from San Francisco State University.

講者簡介:
方瑞賢博士豐富的生物科技初創企業經驗始於其1984年成立的生物醫學器械公司公司Clontech。當時Clontech乃美國境內由亞裔美國人成立的最大的生物醫學器械公司之一在其400名員工中,有65名是擁有博士學位的科學家。1999年方博士將Clontech出售予Becton Dickinson,之後成立了恆信創業投資公司並一直從事風險投資工作至今。透過企業/商務發展的顧問指導方博士至今培育了超過10名非常成功的創業家。

方博士現在是4家生物公司董事會成員,並且參與超過10家估值超過30億美元的公司的合併/收購和上市工作。這些公司的經營範圍涉及:研究器械、醫療診斷和藥物開發。對於這些公司,方博士都在持續增長、價值創造和資金流動性的戰略發展方面發揮了舉足輕重的作用。薪火相傳,那些成功的創業家現於其他初創公司和中型企業擔任領導角色,轉而培養新一代的創業家。 多年以來,方博士擔任過許多領導職位。他曾是中國生物科學院駐北美的主席(2006 -07),三藩市灣區亞美製造商協會的主席(AAMA, 1987)。他也曾擔任加利福尼亞州立大學系統的受託管理委員會成員(2006-13)。此外,他熱衷慈善,慈善活動包括成立三藩市州立大學獎學金、加利福尼亞州立大學(CSU)系統的Kenneth Fong-Hearst捐贈獎學金,以及對北京大學的40名學生提供獎學金。2006年,他參與了在加州大學柏克萊分校建立方氏驗光和醫療圖書館,並在最近捐贈予斯坦福大學設立教授席,以及在三藩市州立大學成立技術轉化捐助基金。

方博士從印第安大學獲得博士學位,並於三藩市州立大學獲得理學士學位。

*photo adapted from: Wealthy Venture capitalist (http://wealthyventurecapitalist.com)

方瑞賢博士在完成其生物醫學學習及研究後,在生物技術產業浸淫了近32年的時間。

他廣為人知的事件是在1984年成立生物科技公司Clontech,經過他的精心培育,Clontech發展為美國境內由亞裔美國人成立的最大的生物醫學器械公司之一,在其400名員工中,有65名是擁有博士學位的科學家。方博士于1999年將Clontech出售予Becton Dickinson,之後成立了Kenson Ventures公司一直從事風險投資工作至今。培育了超過10名非常成功的創業家,給他們提出建議,幫助其公司的發展。

方博士現在是4家生物公司董事會成員,並且參與超過10家估值超過30億美元的公司的合併/收購和上市工作。這些公司的經營範圍涉及:研究器械、醫療診斷和藥物開發。對於這些公司,方博士都在持續增長、價值創造和資金流動性的戰略發展方面發揮了舉足輕重的作用。薪火相傳,那些成功的創業家現於其他初創公司和中型企業擔任領導角色,轉而培養新一代的創業家。

多年以來,方博士擔任過許多領導職位。他曾是中國生物科學院駐北美的主席(2006 -07),三藩市灣區亞美製造商協會的主席(AAMA, 1987)。他也曾擔任加利福尼亞州立大學系統的受託管理委員會成員(2006-13)。此外,他熱衷慈善,慈善活動包括成立三藩市州立大學獎學金、加利福尼亞州立大學(CSU)系統的Kenneth Fong-Hearst捐贈獎學金,以及對北京大學的40名學生提供獎學金。2006年,他參與了在加州大學柏克萊分校建立方氏驗光和醫療圖書館,並在最近捐贈予斯坦福大學設立教授席,以及在三藩市州立大學成立技術轉化捐助基金。

方博士從印第安那大學獲得博士學位,在三藩市州立大學獲得理學士學位。